Stocks Higher, Investors Shrug Off China Trade Retaliation

The U.S. and China continue to spar over trade

Managing Editor
Sep 18, 2018 at 12:00 PM
facebook X logo linkedin


Stocks remain higher this afternoon, despite the latest round of trade threats between the U.S. and China. President Donald Trump said the U.S. will impose 10% tariffs on $200 billion in Chinese goods -- with the exception of some consumer technology products -- with that rate rising to 25% by the end of the year. China, meanwhile, said it will levy tariffs of up to 10% -- instead of the previously announced 25% -- on about $60 billion in U.S. goods, as planned. As such, the Dow Jones Industrial Average (DJI)Nasdaq Composite (IXIC), and S&P 500 Index (SPX) are all sporting healthy gains, with tech stocks leading the charge.

Continue reading for more on today's market, including:

  • The FAANG stock slammed with another bear note.
  • Goldman: Buy this tech stock.
  • Plus, the delivery stock falling on a profit miss; General Mills' latest blow; and the drug stock that's nearly doubled.

Midday Market Stats Sept 18

Package delivery name FedEx Corporation (NYSE:FDX) is sporting unusual options volume today, after the company reported a fiscal first-quarter profit miss. Roughly 22,000 calls and 16,000 puts have crossed the tape for FedEx stock -- seven times the average intraday pace, and pacing for an annual high. The September 240 put -- set to expire Friday -- has been the top trade, with nearly 2,900 contracts exchanged. FDX shares were last seen 4.3% lower to trade at $244.78, sliding back into the red for 2018.

Near the bottom of the New York Stock Exchange (NYSE) today is General Mills, Inc. (NYSE:GIS), after the packaged food company reported a fiscal first-quarter revenue miss. The shares have gapped 8% lower to $43.95, and back below the 50-day moving average, which has been a line of support since mid June. GIS had been inching higher on the charts prior to today, but is now down 25% year-to-date.

Daily Chart of GIS with 50MA

Sporting the top spot on the Nasdaq today is Viking Therapeutics Inc (NASDAQ:VKTX), after the company reported positive mid-stage trial data for its liver disease drug. Viking shares gapped to a record high of $24 out of the gate, and at last check were up 92% at $20.02. The overwhelming price action has catapulted VKTX's year-to-date lead to 403%.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI